Creating a New Class of Curative Medicines

creating a new class

of curative medicines


Cells Talk...A Lot.

Every cell in your body needs to communicate, to keep its neighbors up to date. Much of this communication occurs by proteins that stay on the cell's surface, cell receptors. These communication signals can be subverted when disease occurs. At Bastion, we have discovered a way to hijack these cell receptors: changing their communication to eliminate cancers, autoimmune, and neurologic diseases.

learn how receptor crosslinking is disrupting oncology 


Created in 2015, on research from world-leading chemist Dr. Jindřich “Henry” Kopeček, our polymer antibody conjugate platform uses a unique mechanism of action to crosslink cell receptors, providing transformative solutions for patients, oncologists, and payers.

Artboard 15.jpg